Markets

Radius Health (RDUS) in Focus: Stock Surges 17.3% - Tale of the Tape

Radius Health, Inc. ( RDUS ) was a big mover last session, as the company saw its shares jump over 17% on the day. This rise can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $13.39 to $15.98 in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Radius Health currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked med-drug stocks include Endo International plc ( ENDP ), Hyperion Therapeutics, Inc. ( HPTX ) and Lannett Company, Inc. ( LCI ), all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RADIUS HEALTH (RDUS): Free Stock Analysis Report

ENDO INTL PLC (ENDP): Free Stock Analysis Report

HYPERION THERAP (HPTX): Free Stock Analysis Report

LANNETT INC (LCI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ENDP RDUS LCI

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More